Searched for
EMCURE NET PROFIT
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...
- Emcure Pharma net profit up 36% at Rs 292 croreEmcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...
- Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across ...
- Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growthEmcure Pharmaceuticals reported a strong first quarter with a 41% increase in net profit, reaching Rs 215 crore, and a 16% rise in revenue ...
- Stocks in news: Axis Bank, Tech Mahindra, Wipro, LTIMindtree, Angel OneMarkets remained range-bound due to lack of fresh catalysts, with several companies in focus for Q1 results. Tech Mahindra reported a signi...
- Stocks in news: TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro InfraMarkets experienced volatility within a tight range, closing slightly lower, continuing the consolidation trend. TCS is set to release its ...
- Emcure Pharma shares in focus as Bain Capital likely to offload 2.4% stake via block dealBC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block ...
- Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growthEmcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit to Rs 197 crore, driven by strong domestic and international growth. EBITDA...
- Emcure Pharma Q3 net profit rises 30% YoY to Rs 156 croreEmcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led by strong perfo...
- Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20%Emcure Pharmaceuticals reported a 38.2% YoY rise in Q2FY25 net profit to Rs 202 crore, driven by strong domestic and international sales. R...
- Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue fr...
- Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
- Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other detailsEmcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on ...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- Emcure Pharma files draft paper for Rs 5,000 cr IPOEmcure claims to be an R&D driven company with a differentiated product portfolio that includes orals, injectables and biologics, as well a...
- Generics company Emcure plans Rs 4,000 crore IPOEmcure may appoint as many as six bankers for the IPO including JM Financial, Kotak Capital, Axis Capital and SBI Capital, the people said....
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
Load More
